THE HEALTH CARE COSTS OF LONG-ACTING INSULIN ANALOGS COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES USING A BASAL REGIMEN: A DANISH PERSPECTIVE

被引：0
|
作者：
Gundgaard, J. [1 ]
Christensen, T. [2 ]
Thomsen, T. L. [2 ]
机构：
[1] COWI, Kongens Lyngby, Denmark
[2] Novo Nordisk AS, Virum, Denmark
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72264-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [1] Healthcare costs of long-acting insulin analogues compared with NPH insulin in patients using a basal regimen: a Danish perspective
    Gundgaard, J.
    Aagren, M.
    Thomsen, T. L.
    DIABETOLOGIA, 2009, 52 : S94 - S95
  • [2] Healthcare Costs of Long-Acting Insulin Analogs vs NPH Insulin in Type 2 Diabetes Patients Using a Basal Regimen in Denmark
    Gundgaard, Jens
    Aagren, Mark
    Thomsen, Trine L.
    DIABETES, 2009, 58 : A316 - A317
  • [3] Healthcare Costs of Long-Acting Insulin Analogs vs NPH in Patients with Type 2 Diabetes Using a Basal-Bolus Regimen in Denmark
    Gundgaard, Jens
    Christensen, Torsten
    Thomsen, Trine Lyager
    DIABETES, 2010, 59 : A347 - A347
  • [4] Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen
    Gundgaard, Jens
    Christensen, Torsten E.
    Thomsen, Trine Lyager
    PRIMARY CARE DIABETES, 2010, 4 (03) : 165 - 172
  • [5] Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
    Chang, Chia-Hsuin
    Chuang, Lee-Ming
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04): : 728 - 730
  • [6] THE UTILISATION AND SWITCHING RATES OF NEUTRAL PROTAMINE HAGEDORN (NPH) INSULIN AND LONG-ACTING INSULIN ANALOGS IN PATIENTS WITH TYPE 2 DIABETES IN THE UNITED KINGDOM
    Brunetti, V. C.
    Yu, O. H. Y.
    Platt, R. W.
    Filion, K. B.
    VALUE IN HEALTH, 2020, 23 : S512 - S512
  • [7] Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
    Horvath, K.
    Jeitler, K.
    Berghold, A.
    Ebrahim, S. H.
    Gratzer, T. W.
    Plank, J.
    Kaiser, T.
    Pieber, T. R.
    Siebenhofer, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [8] The utilization of long-acting insulin analogues and intermediate-acting NPH insulin among patients with type 2 diabetes in the United Kingdom
    Brunetti, Vanessa C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 404 - 404
  • [9] Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Aktas, Gulali
    Taslamacioglu Duman, Tuba
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2024, 19 (02) : 155 - 161
  • [10] Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Duman, Tuba Taslamacioglu
    Aktas, Gulali
    Tel, Burcin Meryem Atak
    Bilgin, Satilmis
    Kahveci, Gizem
    Kurtkulagi, Ozge
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2023, 31 (12): : 2039 - 2044
12345